The Asthma Society recommends that people with moderate to severe asthma should receive the flu vaccination. They should also take this opportunity to discuss with their Health Care Professional if they need to have the pneumococcal vaccine, and to have their inhaler technique checked. People most at risk of flu and its complications are the […]
The Asthma Society Issues Vital Flu Vaccine Advice for People with Asthma
November 7, 2011 by Leave a Comment
Management of gestational diabetes mellitus (GDM)
November 1, 2011 by Leave a Comment
Key messages ● Selective screening for GDM should be carried out on identified at risk pregnant women between 24-28 weeks gestation using the 75g oral glucose tolerance test (OGTT). ● Once GDM is diagnosed (see Table 3), patient education, diet and lifestyle alteration, blood glucose monitoring and regular maternal and foetal surveillance is recommended. ● […]
Quick guide to antenatal care for women with pre-existing type 1 or type 2 diabetes
November 1, 2011 by Leave a Comment
Antenatal Care (Types 1 & 2 diabetes) by trimester 1st Trimester Book as soon as pregnancy is confirmed in combined diabetes/obstetric clinic for diabetes and obstetric assessment Review foetal risk/maternal benefit ratio of present medication, and commence/continue folic acid 5mg daily. Type 2: Commence insulin as necessary Refer to dietitian for initial review Perform baseline […]
Blood Glucose Monitoring in the Pregnant and non Pregnant population
November 1, 2011 by Leave a Comment
Table 1: WHO recommendations for the diagnostic criteria for diabetes and intermediate hyperglycaemia in the non pregnant population. Diabetes Fasting plasma glucose ≥7.0mmol/l or 2–h plasma glucose* ≥11.1mmol/l Impaired Glucose Tolerance (IGT) Fasting plasma glucose <7.0mmol/l and 2–h plasma glucose* ≥7.8 and <11.1mmol/l Impaired Fasting Glucose (IFG) Fasting plasma glucose 6.1 to 6.9mmol/l and (if […]
Regular aspirin intake halves risk of hereditary cancer
November 1, 2011 by Leave a Comment
Scientists including those from Queen’s University have discovered that the number of people developing hereditary cancer could be halved by taking regular aspirin. Colorectal cancer is one of the most common forms of hereditary cancers, with 10 per cent of these cancer cases being thought to be hereditary. Some researchers had noticed that patients prescribed […]
Bydureon reduces cardiovascular risk factors
November 1, 2011 by Leave a Comment
Analyses Find Type 2 Diabetes Patients Treated with Bydureon Experienced Reduction in Cardiovascular Risk Factors Eli Lilly & company (Ireland) ltd. wish to announce that Bydureon (exenatide extended-release for injectable suspension) is now available in Ireland as a one weekly injection for the treatment of type 2 diabetes mellitus in combination with metformin, sulphonylurea, and/or […]
Diabetes and Pregnancy – Fact and Figures
November 1, 2011 by Leave a Comment
Prevalence At least 141,000 adults in Ireland (4.7%) have diabetes (diagnosed or undiagnosed) The number of people affected by diabetes in Ireland is increasing. This number is expected to rise to 194,000 or 5.6 % of the population by 2015 – a 37% increase1. In excess of 10% of healthcare spending in Ireland is diabetes […]
Multaq (dronedarone) – Restriction of use and new monitoring requirements
November 1, 2011 by Leave a Comment
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has completed its benefit-risk assessment of Multaq (see IMB Drug Safety Newsletters February and August 2011). As a result of the emergence of safety issues in the post marketing period (hepatic, lung, and the negative inotropic effect), new restrictions for the use of […]
Bloateze
November 1, 2011 by Leave a Comment
Company: Phoenix Healthcare Ltd. Legal category: OTC. Medical device. Sport permitted. Active ingredients: Simethicone 50mg, activated carbon 300mg. Description: Bi-layer tablets. Presentation: 20, €6.63. Indications: Treatment of symptoms related to stomach or intestine bloating due to the accumulation of gas, connected with pain, cramps, flatulence and eructation. Pharmacology: Simethicone is a surfactant; it breaks down […]
Bydureon
November 1, 2011 by Leave a Comment
Company: Eli Lilly & Company (Ireland) Ltd. Legal category: Prescription. GMS. Sport prohibited. Active ingredient: Exenatide 2mg. Description: Powder and solvent for prolonged-release suspension for injection. Presentation: 4 single-dose kits, €89.48. Indication: Treatment of type 2 diabetes mellitus in combination with metformin, sulphonylurea, thiazolidinedione, metformin + sulphonylurea or metformin + thiazolidinedione in adults who have […]
Loading ...
